Daniel Geffken Email and Phone Number
Daniel Geffken is a Founder and Managing Director at Danforth Advisors.
-
Founder And Managing DirectorDanforth AdvisorsCambridge, Ma, Us -
Founder And Managing DirectorDanforth Advisors Aug 2011 - PresentWaltham, Massachusetts, UsDanforth Advisors partners with life science companies to help them start, grow and successfully operate towards their best possible outcomes. We advise and execute in the areas of finance, accounting and operations, providing specialized services that are informed by industry perspective and carried out by consultants who are experienced in this uniquely challenging space. Founded in 2011, we have been a strategic and trusted thought partner to hundreds of life science companies, private and public, across all stages of the corporate life cycle. -
Interim Chief Financial OfficerEloxx Pharmaceuticals Apr 2021 - PresentWatertown, Massachusetts, Us -
Senior Financial AdvisorOlaris, Inc Mar 2021 - PresentFramingham, Massachusetts, Us -
Chief Financial OfficerLocust Walk Acquisition Corp. Dec 2020 - Present
-
Senior Financial AdvisorAffini-T Feb 2021 - Present
-
Senior Financial AdvisorMyeloid Therapeutics Feb 2021 - PresentCambridge, Massachusetts, Us -
Senior Financial AdvisorCentury Therapeutics, Llc Jan 2021 - PresentPhiladelphia, Pennsylvania, Us -
Interim Chief Financial OfficerCalcimedica Nov 2020 - PresentLa Jolla, California, Us -
Interim Chief Financial OfficerDermbiont Therapeutics Oct 2020 - Present
-
Senior Financial AdvisorMatrivax Corporation Jan 2020 - PresentBoston, Massachusetts, Us -
Senior Financial AdvisorPrilenia Mar 2020 - PresentBoston, Massachusetts, Us -
Senior Financial AdvisorNia Therapeutics Mar 2018 - Present
-
Interim Chief Financial OfficerApic Bio, Inc. Mar 2018 - Present
-
Interim Chief Financial OfficerAntolrx, Inc. Jun 2016 - Present
-
Interim Chief Financial Officer And DirectorElicio Therapeutics Apr 2014 - PresentBoston, Massachusetts, Us -
Chief Financial OfficerPromis™ Neurosciences, Inc. Nov 2016 - PresentToronto, Ontario, Ca -
Senior Financial AdvisorPalvella Therapeutics Aug 2020 - Present
-
Interim Chief Financial OfficerBionaut Labs May 2021 - Sep 2022Los Angeles, Ca, Us -
Senior Financial AdvisorAcrivon Therapeutics, Inc. Mar 2021 - Aug 2022Cambridge, Massachusetts, Us -
Interim Chief Financial OfficerVigeo Therapeutics Nov 2017 - Mar 2022
-
Interim Chief Financial OfficerZikani Therapeutics Jul 2019 - Mar 2021
-
Interim Chief Financial OfficerPrivo Technologies Inc Mar 2020 - Jan 2021Peabody, Massachusetts, Us -
Senior Financial AdvisorGraybug Vision, Inc. Sep 2019 - Oct 2020
-
Interim Chief Financial OfficerAtea Pharmaceuticals Jul 2019 - Sep 2020
-
Interim Chief Financial OfficerLysosomal Technologies, Inc. Jul 2013 - Jul 2020
-
Interim Chief Financial OfficerPromedior, Inc May 2012 - Mar 2020
-
Senior Financial AdvisorCabaletta Bio Apr 2018 - Dec 2019Philadelphia, Pennsylvania, Us -
Interim Chief Financial OfficerAquinnah Pharmaceuticals Dec 2017 - Dec 2019
-
Senior Financial AdvisorKallyope, Inc. Sep 2015 - Dec 2019Kalllyope announced in December 2015 a $40M Series A. Congratulations.
-
Interim Chief Financial OfficerStealth Biotherapeutics Nov 2016 - May 2019Needham, Massachusetts, Us -
Senior Financial AdvisorLyra Therapeutics Nov 2015 - Apr 2019Watertown, Massachusetts, Us -
Senior Financial AdvisorImmunsant Oct 2018 - Mar 2019
-
Senior Financial AdvisorStoke Therapeutics Oct 2015 - Feb 2019 -
Interim Chief Financial OfficerRecover Together (Dba, Groups, Inc.) Aug 2017 - Sep 2018
-
Senior Financial AdvisorPear Therapeutics Apr 2016 - Sep 2018
-
Interim Chief Financial OfficerEntrada Therapeutics, Inc. Sep 2016 - Aug 2018
-
Member Board Of DirectorsVyriad, Inc. Sep 2016 - Jul 2018Leader in the development of oncolytic viruses.
-
Interim Chief Financial OfficerGenepeeks, Inc. Aug 2015 - Jun 2018
-
Senior Financial AdvisorImmuneering Corporation Oct 2014 - Jun 2018Cambridge, Ma, Us -
Board Of DirectorsArcturus Therapeutics Nov 2017 - May 2018
-
Interim Chief Financial OfficerOpsonix, Inc. Jul 2015 - May 2018
-
Interim Chief Financial OfficerOpsonix, Inc. Jun 2015 - May 2018
-
Senior Financial AdvisorElucida Oncology, Inc. Nov 2017 - Jan 2018
-
Interim Chief Financial OfficerApellis Pharmaceuticals Aug 2015 - Oct 2017Waltham, Ma, Us -
Board Of Directors; Audit Committee, Compensation CommitteeAlcobra Ltd May 2013 - Oct 2017Alcobra Ltd., founded in 2008 and headquartered in Tel Aviv, Israel, is an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome. Metadoxine Extended Release (MDX) is the company’s lead investigational product candidate. Alcobra trades under the symbol “ADHD” on the NASDAQ Capital Market and the company completed its initial public offering on May 21, 2013. In addition to its headquarters in Tel Aviv, Alcobra has a U.S. office located outside of Philadelphia in Plymouth Meeting, Pennsylvania.
-
Senior Financial AdvisorWntrx Pharmaceuticals Nov 2016 - Jun 2017
-
Senior Financial AdvisorCidara Therapeutics Jan 2013 - Jun 2017San Diego, Ca, Us -
Interim Chief Financial OfficerHomology Medicines, Inc. May 2015 - Mar 2017
-
Senior Financial AdvisorIdeaya Biosciencs Aug 2015 - Dec 2016South San Francisco, California, Us -
Senior Finanical AdvisorGamida Cell Apr 2016 - Oct 2016Boston, Massachusetts, Us -
Senior Financial AdvisorChiasma, Inc. Jan 2015 - Jun 2016
-
Interim Chief Financial OfficerMarina Biotech, Inc. Jan 2014 - Jun 2016City Of Industry, Ca, UsProvide interim financial services to publicly traded mRNA company. -
Senior Financial AdvisorAlcresta, Inc. Oct 2014 - Dec 2015
-
Interim Chief Financial OfficerX4 Therapeutics Mar 2015 - Nov 2015
-
Interim Chief Financial OfficerNew England Venture Capital Association Aug 2013 - Nov 2015Boston, Ma, Us -
Senior Financial AdvisorAltimmune, Inc. Mar 2015 - Oct 2015Gaithersburg, Maryland, Us -
Senior Financial AdvisorGelesis Sep 2014 - Aug 2015Boston, Ma, Us -
Interim Chief Financial OfficerEditas Medicine Sep 2013 - Jul 2015Cambridge, Massachusetts, Us -
Senior Financial AdvisorH3 Biomedicine Feb 2015 - Jun 2015
-
Senior Financial AdvisorAnchor Therapeutics Mar 2012 - Mar 2015Through Danforth Advisors, we provide operational and financial consulting services.
-
Chief Financial OfficerSideris Pharmaceuticals Dec 2012 - Jan 2015
-
Senior Financial ConsultantGenocea Biosciences Jun 2012 - Sep 2014
-
Interim Chief Financial OfficerNovira Therapeutics Aug 2012 - Jun 2014
-
Senior Financial ConsultantLiving Proof, Inc. Aug 2013 - Dec 2013Boston, Ma, UsDeveloped strategic financial plan for prestige brand beauty products company, founded on MIT technology. -
Interim Chief Financial OfficerUsds, Inc. Jul 2011 - Sep 2013
-
Interim CfoBionostics, Inc Jun 2012 - Aug 2013
-
Strategic AdvisorAcusphere Feb 2012 - Jun 2013Through Danforth Advisors, I provide financial strategy consulting and fundraising assistance.
-
Strategic AdvisorInfobionic, Inc. Feb 2012 - Dec 2012
-
Senior Advisor, Finance And OperationsAlgeta Us, Llc Mar 2012 - Nov 2012Oslo, NoThrough Danforth Advisors, I lead senior advisory services in the areas of finance, operations and human resources. Algeta is a publicly-traded Norwegian biotechnology company that is establishing a US sale subsidiary. -
Chief Operating OfficerSeaside Therapeutics Aug 2009 - Feb 2011UsSeaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development. We are dedicated to translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families. -
PrincipalDaniel Geffken Consulting, Llc 2008 - Aug 2009Daniel Geffken Consulting provides financial leadership and strategy consulting to companies in the life sciences and renewable energy industries.
-
Chief Financial OfficerCodon Devices 2006 - 2008
-
Evp, Chief Financial OfficerKonarka Technologies 2006 - 2007Us -
Svp, Chief Financial OfficerOmnisonics Medical Technologies 2003 - 2006Us -
Svp, Chief Financial OfficerTranskaryotic Therapies, Inc. Jan 1997 - Apr 2003 -
Vp, Chief Financial OfficerCytotherpeutics, Inc. 1993 - 1997
-
Chief Financial OfficerMedchem Products 1989 - 1991
-
Senior Audit ManagerKpmg Us 1979 - 1985New York, Ny, Us
Daniel Geffken Education Details
-
Harvard Business SchoolMba -
The Wharton SchoolEconomics
Frequently Asked Questions about Daniel Geffken
What company does Daniel Geffken work for?
Daniel Geffken works for Danforth Advisors
What is Daniel Geffken's role at the current company?
Daniel Geffken's current role is Founder and Managing Director.
What schools did Daniel Geffken attend?
Daniel Geffken attended Harvard Business School, The Wharton School.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial